Analgesic action of the new drug Semax

descriptionPublicationkeyboard_double_arrow_right Article 01 Nov 1996 English Publisher:Springer Science and Business Media LLCJournal:Bulletin of Experimental Biology and Medicine, volume 122, pages 1,107-1,109 (issn: 0007-4888, eissn: 1573-8221,

Copyright policy )

Authors: M. V. Koroleva; E. E. Meizerov; V. N. Nezavibat'ko; A. A. Kamenskii; V. A. Dubynin; Yu. B. Yakovlev;

doi: 10.1007/bf02447659

Analgesic action of the new drug Semax

- Summary
- Metrics

Abstract

Intranasal administration of the new regulatory peptide Semax (0.5 mg/kg) relieves migraine headache and pain caused by dental plexalgia. The analgesic effect of Semax is due to spasmolytic and general regulatory activities but not to its influence on pain sensitivity system.

Related Organizations

Russian Academy of Sciences
Russian Federation
Department of Biological Sciences
Russian Federation
Lomonosov Moscow State University
Russian Federation
Ministry of Health
Russian Federation
Institute of Molecular Genetics
Russian Federation

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average